Custom Health Holdings Inc. CHLT

Custom Health Holdings Inc (TSX:CHLT) reported second-quarter revenue of US$7.4 million, up 70% from a year earlier, as the company advances its medication management platform with two pending acquisitions. The Kelowna, British Columbia-based company said the higher revenue came from its...

For the three months ended June 30, 2026, Custom Health achieved quarterly revenue of US$7.4 million, an increase of 70% from Q2-2025. The results reflect the acquisition of InnovativeRx during the period. The equity pickup for IRX accounts for an acquisition date of June 5, 2026. Proforma Revenue for the combined entity for the 3 months ended June 30, 2026 is US$14.3 million(1).Subsequent to quarter-end, Custom Health entered into a binding letter of intent to acquire Evergreen Pharmacy LLC...

Shane Bishop started his career the way most pharmacists do: behind a counter, handing over a bottle of pills with a short list of warnings. "Take this with food." "This may cause drowsiness." Two minutes, maybe less, then the next patient in line. It didn't take long for him to see the...

Custom Health Holdings (TSX:CHLT) CEO Shane Bishop tells Proactive that the company's acquisition of Spencer Health Solutions has cut hardware costs roughly in half, delivering an immediate margin improvement at the per-patient level. Bishop says the move eliminates duplicated support and cellular coverage costs that existed when the two companies operated separately, and gives Custom Health full control over the product roadmap. Bishop explains that Custom Health had been integrating Spencer Health's medication management device into its core clinical model for several years, and that the tec

Custom Health Holdings Inc (TSX:CHLT) will acquire Spencer Health Solutions Inc, maker of the spencer smart medication dispenser and in-home monitoring platform, in a deal worth up to US$25 million, the company said Wednesday. Custom Health already deploys the spencer device as part of its...

Custom Health has entered into a definitive agreement to acquire Spencer Health Solutions, which is expected to unite Custom Health's pharmacist-led medication management platform with the spencer® in-home smart dispensing and monitoring system, bringing an important in-home medication technology capability fully in-house and further strengthening Custom Health's medication management at home.The Transaction is expected to expand the Corporation's margins by eliminating third-party support and..

Custom Health Holdings Inc (TSX:CHLT) just landed Buy-rated coverage from Stifel, with analysts setting a C$12 price target and pointing to upside as high as C$18 a share. The pitch: a pill-dispensing platform that's quietly solving one of healthcare's most expensive headaches. That...

Custom Health Holdings Inc (TSX:CHLT) has signed a binding letter of intent to acquire Wisconsin-based Evergreen Pharmacy LLC in a deal expected to add more than US$78 million in annual revenue to the company. Under the terms of the letter of intent, Custom Health will pay a total purchase...

Custom Health has entered into a binding letter of intent (the "LOI") to acquire Evergreen Pharmacy LLC ("Evergreen"), a Wisconsin-based specialty pharmacy specializing in the management of complex therapies for chronic disease states.Evergreen generated Revenue of approximately US$78.8 million with Normalized EBITDA (1) of US$0.60 million, for the twelve-month period ended December 31, 2025. Evergreen is a profitable company on both EBITDA and Net Income basis and would be immediately...

Custom Health Holdings Inc (TSX:CHLT) CEO Shane Bishop talked with Proactive about the company's technology-enabled pharmacy model, its expansion strategy and the opportunities ahead following its recent TSX listing. Proactive: Welcome back inside our Proactive newsroom. Joining me today is...

For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million, reflecting total consolidated quarterly revenue of US$12.9 million and proforma annualized revenue run-rate(1) of US$51.6 million.Custom Health successfully completed its public listing and started trading on the Toronto Stock Exchange on June 24, 2026 under the symbol CHLT, significantly enhancing the...

Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - Custom Health Holdings Inc. (TSX: CHLT) (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release dated June 5, 2026, is pleased to announce that it has received final approval for listing on the Toronto Stock Exchange (the "TSX"). The common shares of the Company (CUSIP 23204J104 / ISIN CA23204J1049) ("Common Shares") will commence trading on the TSX under the symbol "CHLT" at market open on..